Benign TumorsFoundation · 9 min read

Dermatofibroma and Fibrohistiocytic Lesions

A central white scar-like patch surrounded by a delicate peripheral pigment network defines classic dermatofibroma, with a growing list of atypical variants demanding histopathologic confirmation.

By Dr. Yehonatan KaplanPublished Updated

In brief

Dermatofibroma (DF), also called cutaneous fibrous histiocytoma, is the prototypic benign fibrohistiocytic lesion of the skin. The classical dermoscopic signature (central white scar-like patch with a peripheral fine pigment network) was described in the early dermoscopy literature and remains the most useful single criterion in routine practice. However, atypical variants (cellular DF, aneurysmal DF, atypical or pseudosarcomatous DF, deep DF, and lesions with unusual color or surface features) account for a meaningful minority of cases and overlap dermoscopically with melanoma, basal cell carcinoma, atypical fibroxanthoma, and dermatofibrosarcoma protuberans. The diagnostic challenge is to recognize the prototype confidently, recognize the variants as variants, and excise anything that does not fit a pigeonhole.

Must-remember points

🎯Central white scar-like patch surrounded by a delicate peripheral pigment network is the high-specificity prototype.
🩺The dimple sign on lateral compression remains a reliable bedside test across phototypes when dermoscopy is ambiguous.
⚠️Cellular and aneurysmal DF variants mimic melanoma and angiokeratoma respectively; atypical lesions go to histology, not monitoring.
🧬Epithelioid cell histiocytoma is now defined by ALK fusions, separating it from classic DF and prompting ALK immunostaining in the workup.
🔍Pigmented BCC, AFX, and melanoma all enter the DF differential when the prototype is incomplete, so any non-classical lesion deserves biopsy.
📊About 80% of classic DFs arise on the legs of women 20-50; lesions at unusual sites carry a higher prior probability of variant or mimic.

Clinical content

01The classical DF presents on the lower extremities of young to middle-aged adults as a firm, slightly hyperpigmented papule with the dimple sign on lateral compression. Dermoscopically, a central white scar-like patch (corresponding to dermal fibrosis with reduced epidermal melanin) sits within a delicate, regular peripheral pigment network (corresponding to acanthotic rete ridges with basal hypermelanosis). Zaballos's foundational study of 412 lesions identified ten dermoscopic patterns: the prototype (central white plus peripheral network) accounted for the largest share, with multiple peripheral white patches, central white network, and homogeneous brown patches as the next most frequent variants.

02The dimple sign (Fitzpatrick sign) is a clinical feature with dermoscopic correlates. Lateral compression of the lesion produces inward depression because the dermal fibrosis tethers the overlying epidermis. Under dermoscopy, the same maneuver may reveal the white scar-like center moving with the dermis rather than sliding over it. The sign is highly specific but not pathognomonic: deep DF and some scars can produce similar tethering.

03Atypical dermatofibromas form a heterogeneous group. Cellular DF is histopathologically more cellular than classic DF and clinically larger, sometimes ulcerated; dermoscopically it often shows polymorphic vessels, central red-blue homogeneous areas, and may lack the typical white patch. Aneurysmal DF (also called hemosiderotic) contains pseudovascular blood-filled spaces and may appear as a blue, purple, or even nodular dark-red lesion clinically; dermoscopically it often shows red-blue or purple lacunar areas resembling angiokeratoma or vascular malformation. Atypical (pseudosarcomatous) DF carries minor histopathologic atypia (occasional mitoses, mild pleomorphism) but behaves benignly; it may show unusual dermoscopic features but is most often diagnosed on histology after excision of an unusual lesion.

04Epithelioid cell histiocytoma (also called epithelioid fibrous histiocytoma) is now recognized as a distinct entity rather than a DF variant. It typically presents as a polypoid or pedunculated reddish papule on the lower extremity, sometimes with a collarette. Dermoscopically it shows red-pink homogeneous areas, polymorphic vessels, and absence of the classic DF features. The 2015 discovery of recurrent ALK gene rearrangements (most often SQSTM1-ALK and VCL-ALK; also DCTN1, PRKAR2A, and ETV6 partners) cemented the entity as biologically distinct, and ALK immunohistochemistry is now part of the differential workup. Recently, ROS-1 fusions and rare FN1-EGFR rearrangements have also been described in cases with epithelioid morphology.

05Deep DF (fibrohistiocytoma profundum, deep benign fibrous histiocytoma) is a rare subcutaneous variant that presents as a firm subcutaneous nodule, usually larger than classic DF, with a higher recurrence rate (about 20% locally) and a preference for the head, neck, and lower extremity. Dermoscopy is limited because the lesion is mainly subcutaneous; surface findings are non-specific (homogeneous skin-color or pink with telangiectasia). Imaging or excisional biopsy is usually required. The differential includes dermatofibrosarcoma protuberans (DFSP), schwannoma, neurofibroma, and lipoma.

06Dermatofibroma in darker skin (Fitzpatrick IV-VI) shows several distinctive features. Pigment is more intense, the peripheral network appears thicker and darker, and the central white patch may be partly obscured by background hyperpigmentation. Postinflammatory hyperpigmentation often surrounds the lesion. The dimple sign and palpable firmness remain reliable across phototypes. Clinically, hypertrophic and keloidal DFs are more common in darker skin and on the chest and back.

07Polypoid and pedunculated DFs occur on the lower extremities, perianal region, and rarely the trunk. They differ from classic DF in shape (raised, sometimes stalked) but retain the dermoscopic vocabulary of central white plus peripheral network when the lesion is photographed obliquely. Lentiginous border (a darkly pigmented periphery resembling a solar lentigo or junctional nevus) is a recognized variant pattern, and the lesion can simulate a melanocytic neoplasm at first glance. Thick, dark, slightly irregular network may shade into atypical network and trigger excision when the central scar-like patch is incomplete.

08Differential diagnosis is the central skill. Atypical fibroxanthoma (AFX) presents on chronically sun-damaged scalp or face of older patients as a rapidly growing red nodule, often ulcerated, with polymorphic vessels and white shiny structures; the absence of the DF prototype features and the actinic context separate the two. Basal cell carcinoma in pigmented form may show a white shiny patch but adds arborizing vessels, blue-grey ovoid nests, leaf-like areas, or spoke-wheel structures. Melanoma rarely mimics DF, but lesions with white scar-like areas plus atypical network, multiple colors, or atypical vessels deserve excision; the rule is that any DF-like lesion that does not fully fit the prototype should be biopsied. ROS-1 positive epithelioid fibroblastic tumors and other emerging fusion-driven entities are increasingly recognized in atypical cases and may require molecular workup.

Key dermoscopic features

Central white scar-like patch
Dermal fibrosis with reduced epidermal melanin; classic DF featureStructureless white area at the center of the lesion, often with sharp inner border
Peripheral fine pigment network
Acanthotic rete ridges with basal hypermelanosis at the lesion peripheryRegular brown network of thin, evenly spaced lines surrounding the central white patch
Multiple white patches
Variant of classic DF with patchy fibrosisSeveral discrete white structureless patches scattered through a brown lesion
Central white network
Inverse of classic pattern; central reticular whiteWhite lines forming a network at the center, with brown structureless areas in between
Polymorphic vessels (cellular DF)
Increased cellularity with prominent vasculatureLinear, dotted, and looped vessels coexisting; sometimes corkscrew vessels in highly cellular cases
Red-blue lacunar areas (aneurysmal DF)
Pseudovascular blood-filled spaces in hemosiderotic variantRed, blue, or purple homogeneous lacunar zones, sometimes mimicking angiokeratoma
Lentiginous (dark) border
Hyperpigmented periphery resembling solar lentigo or junctional nevusDark brown to black peripheral rim, sometimes irregular, surrounding the central scar
Polypoid or pedunculated shape
Variant on legs, perianal region, or trunkRaised or stalked lesion retaining DF dermoscopic vocabulary on oblique imaging
Dimple sign on compression
Pathognomonic clinical-dermoscopic test for DFLesion depresses inward when compressed laterally; central white patch moves with the dermis
Crystalline structures (white shiny streaks)
Polarization-only fibrosis; seen in DF, AFX, melanoma, and BCCShort white lines orthogonal to one another, visible only with polarized dermoscopy
Pink-red homogeneous areas (epithelioid cell histiocytoma)
Distinct ALK-rearranged entity, formerly grouped with DF variantsPink to red structureless areas with polymorphic vessels, polypoid morphology, and no DF prototype features
Skin-colored subcutaneous nodule (deep DF)
Rare subcutaneous fibrohistiocytoma with higher recurrenceFirm subcutaneous mass with non-specific overlying surface, dermoscopy of limited utility

High yield clinical points15 pearls in 3 groups

Recognition & pattern analysis

4 points
1
Dimple sign survives across phototypes. Lateral compression producing inward depression is a clinical test that retains accuracy in dark skin where pigmentation may obscure the dermoscopic prototype. Use it routinely on any firm pigmented papule on the leg.
2
Epithelioid cell histiocytoma is now ALK-defined. Polypoid red papule on the leg of a young to middle-aged adult, especially without DF prototype features, raises ECH. Recurrent ALK fusions (VCL-ALK, SQSTM1-ALK) confirm the entity, and ALK immunohistochemistry is now standard. Recent series describe ROS-1 fusions in rare ALK-negative cases.
3
DF on dark skin shows thicker, darker network. In Fitzpatrick IV-VI patients, the peripheral pigment network appears thicker and the central white patch may be partly obscured by background hyperpigmentation. Postinflammatory hyperpigmentation often surrounds the lesion. The dimple sign and palpation remain reliable when dermoscopy is ambiguous.
4
Trauma history supports but does not establish DF. Many patients recall minor trauma or insect bite at the site months to years before lesion formation. The history strengthens the diagnosis when combined with the dermoscopic prototype and dimple sign, but it is neither sensitive nor specific enough to use alone.

Pitfalls & mimics

8 points
35%
Central white plus peripheral network = classic DF. The combination of a central white scar-like patch and a regular fine peripheral pigment network is highly specific. Zaballos's series of 412 lesions documented this prototype in roughly 35% of DFs and confirmed its discriminatory power against melanocytic and vascular mimics.
80%
Lower extremity remains the home base. About 80% of classic DFs arise on the legs of women aged 20-50, often after minor trauma or insect bites. A lesion that fits the prototype but lives in an unusual site (face, scalp, hand) deserves more scrutiny because variants and mimics dominate at non-classic sites.
3
Cellular DF can mimic melanoma. Increased vascularity, central red-blue homogeneous areas, polymorphic vessels, and absence of the classic white patch make cellular DF a recognized melanoma mimic. Combined with the slightly larger size and occasional ulceration, the prudent move is excision and histology rather than monitoring.
4
Aneurysmal DF mimics vascular tumors. Hemosiderotic / aneurysmal DF can show red-blue or purple lacunae closely resembling angiokeratoma or thrombosed vascular lesion. When dermoscopic vascular features dominate but the lesion is firm and palpable on the leg, keep aneurysmal DF on the differential and biopsy.
5
Lentiginous border is a known DF mimic of nevus. Some DFs develop a darkly pigmented peripheral rim resembling a junctional nevus or solar lentigo. Combined with the firm consistency on palpation and the central scar-like patch, the lentiginous DF is benign but commonly excised because the dermoscopic signal toward melanocytic neoplasia is strong.
6
Atypical fibroxanthoma is the older-patient mimic. Rapidly growing red ulcerated nodule on chronically sun-damaged scalp or face of an elderly patient, with polymorphic vessels and white shiny streaks but no DF prototype, is AFX until proved otherwise. Excise; AFX is histopathologically a diagnosis of exclusion against pleomorphic dermal sarcoma.
7
Anything not a perfect prototype deserves biopsy. The classical DF is highly recognizable. When the lesion lacks a clear central white patch, lacks a regular peripheral network, shows polymorphic vessels, multiple colors, asymmetry, or atypical vascular features, it falls into the variant zone and the safest move is excisional biopsy. The cost of excising an atypical DF is low; the cost of missing melanoma, AFX, or fusion-driven sarcoma is not.
8
ROS-1 epithelioid fibroblasts mark new fusion entity. Recent series describe ROS-1 fusion-positive epithelioid fibroblastic tumors that overlap morphologically with epithelioid cell histiocytoma but are ALK-negative. They likely represent a distinct entity within the fibrohistiocytic spectrum and may have implications for targeted therapy in rare malignant counterparts.

When to biopsy

3 points
1
Deep DF carries a 20% recurrence rate. Subcutaneous deep DF recurs locally in roughly one in five cases after marginal excision. Wider clear margins and follow-up are warranted, and DFSP must be excluded by CD34 immunohistochemistry on the resection specimen.
2
Pigmented BCC enters the differential through white patches. Pigmented BCC may show a white scar-like area but adds arborizing vessels, blue-grey ovoid nests, leaf-like areas, or spoke-wheel structures. Absence of any of these BCC clues plus presence of the DF prototype and dimple sign supports DF; mixed features warrant biopsy.
3
Polypoid DF on legs and perianal region. Polypoid and pedunculated variants retain the DF vocabulary on oblique dermoscopy. Common sites include the legs (especially around old shave biopsies), perianal region, and rarely the trunk. Lesions that resemble fibroepithelial polyp or skin tag but feel firm and tethered should be sampled.

Lectures covering this topic5 lectures

Notable updates & conceptual milestones5 updates

Ten-pattern dermoscopic classification

2008

Zaballos's 2008 study of 412 dermatofibromas defined ten distinct dermoscopic patterns and quantified their frequency, providing the empirical basis for routine pattern recognition.

ALK-rearranged epithelioid cell histiocytoma

2016

Recurrent ALK fusions (most often VCL-ALK and SQSTM1-ALK) were identified in 2016 as defining molecular events in epithelioid cell histiocytoma, separating it from classic DF and motivating ALK immunohistochemistry in the workup.

ROS-1 and FN1-EGFR fusions in fibrohistiocytic spectrum

2021

Recent case series have described ROS-1 fusion-positive epithelioid fibroblastic tumors and rare FN1-EGFR rearrangements, expanding the molecular landscape of cutaneous fibrohistiocytic neoplasms beyond classical DF.

Dimple sign as bedside-dermoscopy crosswalk

2010

Combining the classical dimple sign on lateral compression with dermoscopic verification of the central white patch tethered to the dermis raises diagnostic confidence in equivocal cases, particularly in dark skin where the network may be obscured.

Recognition of aneurysmal DF as melanoma mimic

2012

Aneurysmal (hemosiderotic) DF was repeatedly highlighted in the dermoscopy literature as a melanoma mimic because of its red-blue or purple lacunae, polymorphic vessels, and occasional asymmetric pigmentation. Awareness drives excision rather than monitoring of equivocal blue-purple firm lesions.

Bottom line

When the lesion is a firm leg papule with a central white scar-like patch, a fine peripheral network, and a positive dimple sign, dermatofibroma is confidently diagnosed and observation is appropriate. Anything that deviates from this prototype (cellular, aneurysmal, deep, atypical, polypoid, lentiginous, or unusual site) should be excised because the differential includes melanoma, AFX, BCC, DFSP, and emerging fusion-driven entities.

Molecular characterization will continue to subdivide the fibrohistiocytic spectrum. ALK-positive epithelioid cell histiocytoma is the established example, ROS-1 fusion-positive epithelioid fibroblastic tumors are an emerging cohort, and routine fusion panels in atypical fibrohistiocytic lesions will likely identify additional entities with prognostic and therapeutic relevance.

References

Sources cited in the lecture content or that underpin the clinical points above. Verify with primary sources before practice changes.

  1. [1]
    Zaballos P, Puig S, Llambrich A, Malvehy J. Dermoscopy of dermatofibromas: a prospective morphological study of 412 cases. Arch Dermatol 2008;144:75-83.
    PubMed: 18209171DOI: 10.1001/archdermatol.2007.8· Foundational ten-pattern classification underpinning routine DF dermoscopy.
  2. [2]
    Ferrari A, Argenziano G, Buccini P, et al. Typical and atypical dermoscopic presentations of dermatofibroma. J Eur Acad Dermatol Venereol 2013;27:1375-1380.
    PubMed: 23176079DOI: 10.1111/j.1468-3083.2012.04676.x· Documented atypical DF subtypes (cellular, aneurysmal, lentiginous border) and their dermoscopic features.
  3. [3]
    Doyle LA, Marino-Enriquez A, Fletcher CD, Hornick JL. ALK rearrangement and overexpression in epithelioid fibrous histiocytoma. Mod Pathol 2015;28:904-912.
    PubMed: 25857825DOI: 10.1038/modpathol.2015.49· Defining paper on ALK fusions establishing epithelioid cell histiocytoma as a distinct entity from classic DF.
  4. [4]
    Agaimy A, Tirado CA, Laskin WB, et al. Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors. Mod Pathol 2021;34:1507-1520.
    PubMed: 33742141DOI: 10.1038/s41379-021-00789-8· Example of expanding fusion-driven landscape in cutaneous and soft tissue fibrohistiocytic neoplasms.
  5. [5]
    Han TY, Chang HS, Lee JH, Lee WM, Son SJ. A clinical and histopathological study of 122 cases of dermatofibroma (benign fibrous histiocytoma). Ann Dermatol 2011;23:185-192.
    PubMed: 21747617DOI: 10.5021/ad.2011.23.2.185· Clinicopathologic series with site distribution and histologic subtypes including deep variants.
  6. [6]
    Bakos RM, Cartell A, Bakos L. Dermatoscopy of early-stage dermatofibrosarcoma protuberans. J Eur Acad Dermatol Venereol 2018;32:e285-e286.
    PubMed: 29377285DOI: 10.1111/jdv.14808· Differential dermoscopy distinguishing DFSP from deep DF and other fibrohistiocytic mimics.
  7. [7]
    Arpaia N, Cassano N, Vena GA. Dermoscopic patterns of dermatofibroma. Dermatol Surg 2005;31:1336-1339.
    PubMed: 16188191DOI: 10.1111/j.1524-4725.2005.31213· Earlier series corroborating the central white patch plus peripheral network prototype.